Global Non-Invasive Prenatal Testing (NIPT) Market to Grow $5.67 Billion by 2028

Thursday, October 25, 2018 Women Health News
Email Print This Page Comment bookmark
Font : A-A+

FREMONT, California, October 25, 2018 /PRNewswire/ --

According to a new market intelligence report by BIS Research,

titled "Global Non-Invasive Prenatal Testing (NIPT) Market - Analysis and Forecast, 2018-2028", the global NIPT is anticipated to grow over $5.67 billion with 7,591,792 units by 2028. The global NIPT market is projected
to grow with a CAGR of 13.07% between the years 2018 and 2028, aided by the remarkable growth in the IONA test, trisomy detection, and NGS segments.

     (Logo: )

Browse 21 market Data Tables and 225 Figures spread through 406 Slides and in-depth TOC on 'Global Non-Invasive Prenatal Testing (NIPT) Market'

Technological advancements in the healthcare industry have always played a crucial role in its overall development. Among the innumerable advancements witnessed by the industry, NIPT today stands as one of the most distinctive technologies in curbing the concerns related to genetic diseases. The recent advancements in the life science industry, such as wearable healthcare devices, sequencing technologies, regenerative medicine, and genomic technologies, supported by breakthroughs in the field of genome sequencing and molecular research have opened new and promising pathways to combat genetic diseases and reduce the overall global economic burden.

Prenatal testing has become the need of the hour owing to the increasing number of cases of genetic disorders, such as Down syndrome, spina bifida, cleft palate, sickle cell anemia, thalassemia, fragile X syndrome, and Tay-Sachs disease, among others. Further, all of these conditions are the consequences of the mutant genes and an abnormal chromosomal structure. Therefore, prenatal testing prerequisites the patient to be mentally prepared and helps them to take a decision either to continue or to abort the pregnancy. This has widened the scope of prenatal testing in the IVF market, as the chances of heredity diseases increase in cases where egg and sperm of donors are used for the fertilization process.

There are several methods in prenatal testing such as amniocentesis, chronic villus sampling, maternal serum screening, and non-invasive prenatal testing (NIPT), among others. NIPT is used for screening pregnant women who are at high risk of developing fetal chromosomal aneuploidies such as Down syndrome (trisomy 21), Edward's syndrome (trisomy 18), Patau's syndrome (trisomy 13), and Turner syndrome (monosomy X). The NIPT market growth is propelling due to various factors, such as increasing demand for non-invasive diagnostic procedures, technological advancements, increasing prevalence of genetic disorders, and government initiatives for reimbursement policies, across the globe.

BIS Research Report:

According to Pushplata Patel, Analyst at BIS Research, "North America is the leading contributor to the global NIPT market. The contribution of North America to the global NIPT market was valued approximately 51.55% and 52.31% in terms of revenue and volume respectively in 2017.  Fields such as the IONA test and trisomy detection application are expected to progress at significant rates. Further, the significant development in the reimbursement policies in the region is consequentially fueling the growth of NIPT market in North America. However, the region of Asia-Pacific is expected to grow at an impressive CAGR of 18.01% and 19.13% in terms of revenue and volume respectively during the forecast period (2018 - 2028). The Asia-Pacific market contributed approximately 20.12% of the total global market value in 2017."

Research Highlights: 

  • The emergence of the prenatal testing with next-generation sequencing (NGS) technology has enabled the reduction in turnaround time and increased accuracy & efficiency of early diagnosis of chromosomal abnormalities.
  • Currently, the trisomy application of NIPT is the major contributor to the global NIPT market and is expected to grow at a CAGR of 15.17% and 16.50% % in terms of revenue and volume respectively during the forecast period.
  • The global NIPT market is constituted of significant contributions from several conglomerate and small-medium enterprises. More than 33 products from approximately 21 companies are available in the market.
  • The IONA test is expected to witness a robust CAGR of 22.12% and 24.26% in terms of revenue and volume respectively during the forecast period (2018 - 2028). Further, the NIPT market for Asia-Pacific is anticipated to witness remarkable growth, owing to the increasing prevalence of Down syndrome and increasing adoption of prenatal testing.

This market intelligence report provides a multidimensional view of the global NIPT market in terms of the market size and growth potential. This research report aims at answering various aspects of the global NIPT market with the help of the key factors driving the market, threats that can inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion.

Request a sample:

Furthermore, the competitive landscape chapter in the report explicates the competitive nature of the global market and enables the reader to get acquainted with the recent market activities, such as product launches, regulatory clearance, and certifications, partnerships, collaborations, business expansions as well as mergers and acquisitions, among others. The research report provides a comprehensive analysis of the product sales & manufacturers, trend analysis by segments, and demand analysis by regions.

This report is a meticulous compilation of research on more than 70 players in the market ecosystem and draws upon insights from in-depth interviews with the key opinion leaders of more than 30 leading companies, market participants, and vendors. The report also profiles 17 companies including several key players, such as Agilent Technologies, Inc., Annoroad Gene Technology, Berry Genomics Co., Ltd., BGI Diagnosis, Centogene AG, Counsyl, Inc., Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., Next Biosciences, NIPD Genetics, PerkinElmer, Inc., Premaitha Health Plc, and Quest Diagnostics Incorporated.

Key questions answered in the report: 

  • How has the NIPT market evolved, and what is its scope in the future?
  • What are the major market drivers, challenges, and opportunities in the global NIPT market?
  • What are the key developmental strategies that are implemented by the key players to sustain in this market?
  • How the influencing factors will affect the industry attractiveness?
  • How NIPT is utilized for the detection of chromosomal abnormalities?
  • How investments by public and private companies and government organizations will affect the global NIPT market?
  • What was the market size of the leading segments and sub-segments of the global NIPT market in 2017?
  • How will the industry evolve during the forecast period 2018-2028?
  • What will be the growth rate of the NIPT during the forecast period?
  • How will each segment of the global NIPT market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2028?
  • Which test segment and application segment is expected to register the highest CAGR for the NIPT market?
  • What is the market size of NIPT in different countries of the world?
  • Which geographical region will contribute to the highest sales of NIPT?
  • Who are the key players in the NIPT market, and what are their contributions?

Related Reports: 

Global Liquid Biopsy Market - Analysis and Forecast (2018-2028)

Global Companion Diagnostics (CDx) Market - Analysis and Forecast (2018-2025)

Global Cell Free DNA Isolation and Extraction Market -Analysis and Forecast (2018-2026)

Global Point of Care Testing Market -Analysis and Forecast (2017-2026)

About BIS Research:  

BIS Research is a global B2B market intelligence and advisory firm focusing on those emerging technological trends which are likely to disrupt the dynamics of the market.

With over 150 market research reports published annually, BIS Research focuses on high technology verticals such as 3D Printing, Advanced Materials and Chemicals, Aerospace and Defense, Automotive, Healthcare, Electronics and Semiconductors, Robotics and UAV, and other emerging technologies.

Our in-depth market intelligence reports focus on the market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.

What distinguishes BIS Research from the rest of the players is that we don't simply provide data but also complement it with valuable insights and actionable inputs for the success of our clients.

Contact: Bhavya Banga Email: BIS Research Inc. 39111 PASEO PADRE PKWY STE 313, FREMONT CA 94538-1686

Visit our Blog@ Connect with us on LinkedIn@ Connect with us on Twitter@


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store